FORTUNE -- Every smart investors knows you should aim to buy low and sell high, so why is the concept lost on managers of public companies?
As Will Becker, analyst at Behind the Numbers, shows in a new report to clients on the trend of increased share buybacks, when company management buys back its own stock, it tends to do it when market valuations are high, not low. And that's exactly what's happened over the past year as the S&P 500 repeatedly reached new heights.
According to data assembled by Becker, S&P 500 companies increased the total dollar amount of share buybacks they engaged in by 28.5% year-over-year in the fourth quarter of 2013, to $126 billion. "While this represents a sequential increase of just 1.7% from 3Q13, S&P 500 companies have been more active over the trailing twelve months ended 12/31/13 than in any period since the financial crisis," he writes.
A few more stats from Becker's report:
Defenders of share buyback schemes often point to the fact that a buyback can help companies and investors reduce their tax liabilities. For instance, a company can borrow money to repurchase shares and deduct the interest paid on debt. At the same time, some investors would rather their investments appreciate through share buybacks than receive a dividend because they must immediately pay taxes on dividends but not gains on stock they haven't sold.
Others argue that share repurchases should be a natural step in a company's lifecycle. Firms competing in declining industries with few good capital investment options must find a way to return profits to their shareholders, and share buybacks are an effective way to wind down a struggling company in a way that keeps shareholders and executives happy.
But what about companies operating in arguably thriving industries, like pharmaceuticals, that will only grow more profitable as the population within wealthy nations ages? In his report, Becker fingers pharma company Pfizer (PFE) as one such firm with few good excuses for buying back so many of its shares. Pfizer has been hit hard by the expiration of patents on two of its best-selling drugs, Lipitor and Viagra, in recent years, and it has been, according to Becker, "scrambling" to replace that revenue with cost cutting, acquisitions, and restructuring of its R&D efforts.
But instead of pouring its profits into developing new drugs, Pfizer has been busy buying back huge amounts of its own stock -- $16.3 billion worth in 2013. Becker argues that the company's move may have as much to do with executives hoping to reduce the total number of shares in circulation so that they can meet certain stock-price based performance metrics as it has to do with the belief that Pfizer shares are undervalued. Writes Becker:
Looking at PFE's annual incentive program, a pool is funded based on the company's performance on three financial metrics: total revenue, adjusted diluted earnings per share and cash flow from operations ... largely with the aid of its record share repurchase activity, PFE managed to exceed the 2013 target goal fro adjusted diluted EPS, while producing slightly below-target performance for its revenue and cash flow metrics.
While Pfizer didn't have a particularly stellar 2013, its executives still received healthy bonuses, in part because Pfizer surpassed its goals for growth in earnings per share, a goal that wouldn't have been met without such a concerted effort to keep the total number of shares outstanding low. Meanwhile, Pfizer has reduced its investment in research and development as a percentage of revenue every year since 2007 -- which can't bode well for the company's prospects of launching the next Lipitor or Viagra.
Becker believes Autozone (AZO) is also a bit too fond of share buybacks and that its CEO William Rhodes stands to be a chief beneficiary of the strategy, as "a material amount of his future compensation is tied to diluted EPS targets." Like Pfizer, the money to buy back shares has forced Autozone to reduce investment elsewhere in the company as it has recently reported a cash flow deficit and has had to take on hundreds of millions of dollars in new debt.
Becker also points to companies like Sysco (SYY), Jarden (JAH), and Brinker International (EAT) as firms buying back for the wrong reasons, but there are surely many more out there. And as the stock market continues to rise, investors should be ever more wary of investing in companies that would rather buy back shares of their own stock at high valuations than invest in its business, the ostensible generator of capital gains.
More energy companies are converting to a tax-free status that was once reserved for a small segment of the industry.
FORTUNE -- More and more of the companies benefiting from new technologies that are fueling America's recent energy boom are paying little or no taxes.
In early May, Emerge Energy Services sold $127 million in shares in an initial public offering. Emerge (EMES) supplies sand to oil and gas drillers for blasting MOREStephen Gandel, senior editor - May 28, 2013 9:19 AM ET
Income is the new Facebook.
FORTUNE -- All of a sudden, the market for initial public offerings seems to be dominated by stocks only widows and orphans used to love.
In the past six months, nearly half of all companies that sold shares through an IPO, or 26 in total, have paid a dividend. Some are pretty big. For instance, Zais Financial Corp. (ZFC), a REIT that went public in early February, MOREStephen Gandel, senior editor - Apr 15, 2013 6:00 AM ET
Progressive has an intelligent, rational, and transparent way to deal with the surplus cash that its operations generate. Apple doesn't.
FORTUNE -- The folks at Apple could learn a lot from Progressive Corp., the auto insurance company made famous by the ubiquitous Flo, star of its endless flow of ads.
Apple doesn't need help from Progressive when it comes to selling products. But Apple could really profit by studying how Progressive deals MOREAllan Sloan, senior editor-at-large - Feb 22, 2013 5:00 AM ET
Why it's more important than ever to focus on the dividends and buybacks that companies return to shareholders.
FORTUNE -- Dividend-paying stocks have generated intense debate in recent years. Has the rising market made their prices too high and their yields too low -- or is a dividend-heavy portfolio still the best way to garner superior returns? For Chris Brightman, that discussion misses the point. Brightman is the head of investment MOREShawn Tully, senior editor-at-large - Feb 14, 2013 5:00 AM ET
The giant retailer is borrowing billions to dole out to shareholders in a special dividend before the fiscal cliff hits.
FORTUNE -- If you could afford to borrow $10,000 at an 0.8% interest rate to blow in Las Vegas or on a 5-star meal with your friends, would you? Should you?
That's the question facing shareholders of Costco (COST). Last week, the warehouse merchant said that it was paying out a special MOREStephen Gandel, senior editor - Dec 3, 2012 7:00 AM ET
Income-starved investors have a surprising new option: dividend-paying stocks in emerging markets.
By Janice Revell, contributor
FORTUNE -- In a world where 10-year Treasury bonds are yielding a mere 1.5%, it makes sense that investors are flocking to blue-chip U.S. dividend-paying stocks to add income to their portfolios. But you might want to expand your horizons to a more unlikely source of yield: emerging markets. Companies operating in countries such MOREAug 9, 2012 5:00 AM ET
His investment style may be hot these days, but Federated fund manager Daniel Peris views it as the oldest way to play the market.
FORTUNE -- Daniel Peris is a dividend purist. It's not just that he hunts for companies able to deliver high returns via dividends. It's that he views dividends as the fundamental drivers of the stock market. In his view the size of the cash payouts and MOREScott Cendrowski, writer - Mar 28, 2012 5:00 AM ET
They offer yields so lofty they're likely to fall. But mREITs may still have potential for investors.
By Jon Birger, contributor
FORTUNE -- As bond, CD, and money market interest rates remain mired at rock-bottom levels, investors continue their quest for dividends. One category offers eye-popping yields: mortgage real estate investment trusts, or mREITs (which are required to pass most of their income to shareholders via dividends). Chimera Investment and American Capital MOREJan 11, 2012 5:00 AM ET
Based on current valuations, it looks like a great time to invest in companies with solid fundamentals. But we still recommend erring on the side of caution.
By Jon Birger, contributor
FORTUNE -- How do you pick stocks in a market defined by unpredictability? With caution and a heavy dose of humility.
Consider the fate of our Best Stocks for 2011. A year ago, we identified 10 reasonably priced growth companies (average price/earnings MOREDec 8, 2011 5:00 AM ET
|Canadians arrest a Heartbleed hacker|
|5 people you might not tip (but should)|
|US Airways won't fire worker who sent lewd tweet|
|Toyota unveils redesigned Camry|
|Feel good Wednesday: Markets up 1%|